Project Grant R01CA218306
Award Date 9/1/17
Completion Date 8/31/22
Dollars Obligated $1.1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Argentina
Similar Awards
- This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $233,411 to Pennsylvania State University's Milton S. Hershey Medical Center to conduct a randomized controlled trial (RCT) evaluating a narrative communication intervention delivered through digital and mobile technology. The goal is to understand how narrative messaging can influence HPV vaccine decision-making and increase HPV vaccine initiation rates among parents of...
- This $157,744 Project Grant award from the Agency for Healthcare Research and Quality (AHRQ) under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program will fund a research project to develop and pilot an intervention to increase human papillomavirus (HPV) vaccination coverage among rural adolescents in North Carolina. The key objectives are to: 1) define optimal systems for recommending HPV vaccination at age 9 in rural clinics; 2) assess acceptability of age-9 HPV...
- GRANT AWARD SUMMARY Tufts Medical Center Parent, Inc. (doing business as Tufts Medical Center) received a $3.28 million Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded August 15, 2025, with a completion date of July 31, 2029. The grant funds development and evaluation of a Conversational Agent to Improve Guideline Concordant Care for People with Cervical Cancer Screening Abnormalities (ECA-CCSA). The primary...
- This federal Project Grant award of $753,446.00 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) aims to adapt and test an intervention to improve cervical cancer screening and follow-up in three diverse, underserved populations: urban inner city Blacks/Haitians in Boston, Hispanic immigrants in Florida, and Hawaiian Natives/Pacific Islanders in Hawaii. The project, titled "Development of Systems and Education for Cervical...
- This $5.37 million project grant from the National Institutes of Health National Institute on Drug Abuse will fund the development of a context-aware digital adherence intervention called SMARTSTEPS to improve pre-exposure prophylaxis (PrEP) adherence among men who have sex with men with substance use disorder. The grant will support two phases. Phase I will inform the specification of an algorithm that utilizes digital phenotyping data from a smartphone app to anticipate non-adherence based...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...
- Federal Project Grant Award Summary The University of North Carolina at Chapel Hill received a $165,012 Project Grant from the National Institute for Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research program (CFDA 93.307), awarded September 14, 2025, with a completion date of March 31, 2029. This award funds a multi-level, community-engaged intervention designed to improve access to cervical cancer screening in rural North Carolina by...
- Federal Project Grant Award Summary The University of Washington received a $205,948 Project Grant (R21) award from the National Institute of Nursing Research (NINR) under the Nursing Research program (CFDA 93.361), effective August 1, 2025 through June 30, 2027. This award supports research examining the mechanisms of action (MOA) for a mobile SMS-based Pre-Exposure Prophylaxis (PrEP) adherence intervention designed to improve HIV prevention outcomes among cisgender women in Kenya. The...
- This Project Grant award of $173,197 from the Fogarty International Center (CFDA 93.989 - International Research and Research Training) supports a collaborative research project between Brown University, Beijing Normal University, and Emory University. The project aims to develop and test a mobile health (mHealth) intervention focused on stigma reduction and gender affirmation to engage Chinese transgender women in HIV prevention, mental health promotion, and access to community resources. The...
- The U.S. Agency for Healthcare Research and Quality (AHRQ) awarded a $399,111 Project Grant under the Research on Healthcare Costs, Quality and Outcomes (CFDA 93.226) program to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH). The grant aims to increase postpartum primary care engagement, quality, and experience by strengthening coordination between obstetric and primary care providers. The intervention includes default primary care visit scheduling,...
MIXED-METHODS APPROACH TO EVALUATE A MHEALTH INTERVENTION TO INCREASE ADHERENCE TO TRIAGE OF HPV+ WOMEN WHO HAVE PERFORMED SELF-COLLECTION
Posted 8/29/17
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 4/27/23 | ||
| Not listed | $0 | 8/18/21 | ||
| Not listed | $0 | 8/18/21 | ||
| Not listed | $336.9k | 8/30/19 | ||
| Not listed | $393.2k | 8/29/18 |